← SynDRA
AKOS025404937
SynDRA canonical compound SYN1607203 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EZH2 |
|---|
| Mechanism of action | histone lysine methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- histone lysine methyltransferase inhibitor
Cross-references
Synonyms
- CPI-169
- CPI-169 R-ENANTIOMER
- CS-3174
- HY-15956A
- Cpi-169
- RefChem:919144
- CPI 169 R-enantiomer
- SCHEMBL19554395
- SCHEMBL22363254
- SCHEMBL29351323
- EX-A675
- CHEBI:131155
- CPI-169(R)
- GLXC-07509
- EX-A1684
- s7616
- CCG-269906
- NCGC00390589-01
- NCGC00390589-02
- AC-35582
- FC137666
- BRD-K97181972-001-01-9
- 1-[(1R)-1-(1-ethylsulfonyl-4-piperidinyl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-3-indolecarboxamide
Look up AKOS025404937 in the interactive SynDRA portal →